RenovoRx Inc (RNXT)

RenovoRx Inc. has seen no insider trading activity within the last three months. The most recent transaction occurred on May 19, 2026, when the Chief Financial Officer purchased shares. Prior to this, various executives consistently acquired equity throughout 2025 and early 2026, reflecting a pattern of accumulation by leadership.
Ticker: RNXT Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for RenovoRx Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
VOLL MARK Chief Financial Officer Officer
Transaction date
Purchase
Price
430.31
Quantity 78,486 +29.8%
Value US$1,203,206
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
345.07
Quantity 84,108 -13.5%
Value US$3,775,224
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
171.62
Quantity 92,481 -20.7%
Value US$3,177,526
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.83
Quantity 205 +0.0%
Value US$169
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.90
Quantity 5,000 +1.5%
Value US$4,506
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.85
Quantity 5,000 +1.5%
Value US$4,262
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.85
Quantity 12,000 +1.6%
Value US$10,200
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.96
Quantity 10,000 +1.3%
Value US$9,600
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.80
Quantity 12,000 +1.6%
Value US$9,600
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.80
Quantity 10,000 +1.4%
Value US$8,000
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.91
Quantity 5,000 +1.5%
Value US$4,549
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.95
Quantity 5,000 +1.6%
Value US$4,748
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
1.40
Quantity 21,000 +2.9%
Value US$29,400
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.90
Quantity 15,000 +1.4%
Value US$13,500
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.91
Quantity 7,500 +2.4%
Value US$6,821
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.80
Quantity 20,000 +1.9%
Value US$16,000
3.6
Kocak Ron VP Controller and PAO Officer
Transaction date
Purchase
Price
0.79
Quantity 6,500 +106.6%
Value US$5,135
3.6
Kocak Ron VP Controller and PAO Officer
Transaction date
Purchase
Price
0.80
Quantity 6,000 +6315.8%
Value US$4,800
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.81
Quantity 30,000 +2.9%
Value US$24,399
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.83
Quantity 10,000 +3.3%
Value US$8,300
3.6
Kocak Ron VP Controller and PAO Officer
Transaction date
Purchase
Price
0.80
Quantity 95 +inf%
Value US$76
3.3
Marton Laurence Non-Executive Director
Transaction date
Purchase
Price
0.85
Quantity 12,050 +35.8%
Value US$10,218
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.84
Quantity 26,000 +2.5%
Value US$21,840
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.83
Quantity 10,000 +3.4%
Value US$8,300
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.00
Quantity 40,983
Value US$0
Macfarlane K. Angela Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 40,983
Value US$0
Spiegel Robert J. Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 40,983
Value US$0
3.9
Agah Ramtin Chief Medical Officer Executive Director
Transaction date
Purchase
Price
0.00
Quantity 40,983
Value US$0
3.3
Marton Laurence Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 8,196
Value US$0
2.5
Nelms Angela Chief Operating Officer Officer
Transaction date
Purchase
Price
1.05
Quantity 800 +266.7%
Value US$836
2.5
Nelms Angela Chief Operating Officer Officer
Transaction date
Purchase
Price
1.05
Quantity 300 +inf%
Value US$315
3.9
Agah Ramtin Chief Medical Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.93
Quantity 5,182 +400.2%
Value US$10,001
4.0
Bagai Shaun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.05
Quantity 5,500 +2.2%
Value US$11,275
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-21 2026-05-19 B Purchase

Chief Financial Officer

Officer
78,486 +29.8%
430.31
US$1,203,206
78,486 +29.8% 430.31 US$1,203,206
2026-01-22 2026-01-21 B Purchase

Chief Medical Officer

Executive Director
84,108 -13.5%
345.07
US$3,775,224
84,108 -13.5% 345.07 US$3,775,224
2026-01-05 2025-12-31 B Purchase

Chief Medical Officer

Executive Director
92,481 -20.7%
171.62
US$3,177,526
92,481 -20.7% 171.62 US$3,177,526
2026-01-02 2025-12-30 B Purchase

Chief Medical Officer

Executive Director
205 +0.0%
0.83
US$169
205 +0.0% 0.83 US$169
2025-12-22 2025-12-18 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.5%
0.90
US$4,506
5,000 +1.5% 0.90 US$4,506
2025-12-19 2025-12-17 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.5%
0.85
US$4,262
5,000 +1.5% 0.85 US$4,262
2025-12-17 2025-12-16 B Purchase

Chief Medical Officer

Executive Director
12,000 +1.6%
0.85
US$10,200
12,000 +1.6% 0.85 US$10,200
2025-12-08 2025-12-05 B Purchase

Chief Medical Officer

Executive Director
10,000 +1.3%
0.96
US$9,600
10,000 +1.3% 0.96 US$9,600
2025-11-24 2025-11-24 B Purchase

Chief Medical Officer

Executive Director
12,000 +1.6%
0.80
US$9,600
12,000 +1.6% 0.80 US$9,600
2025-11-24 2025-11-21 B Purchase

Chief Medical Officer

Executive Director
10,000 +1.4%
0.80
US$8,000
10,000 +1.4% 0.80 US$8,000
2025-08-26 2025-08-25 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.5%
0.91
US$4,549
5,000 +1.5% 0.91 US$4,549
2025-08-26 2025-08-22 B Purchase

Chief Executive Officer

Executive Director
5,000 +1.6%
0.95
US$4,748
5,000 +1.6% 0.95 US$4,748
2025-06-09 2025-06-05 B Purchase

Chief Medical Officer

Executive Director
21,000 +2.9%
1.40
US$29,400
21,000 +2.9% 1.40 US$29,400
2025-04-17 2025-04-15 B Purchase

Chief Medical Officer

Executive Director
15,000 +1.4%
0.90
US$13,500
15,000 +1.4% 0.90 US$13,500
2025-04-16 2025-04-15 B Purchase

Chief Executive Officer

Executive Director
7,500 +2.4%
0.91
US$6,821
7,500 +2.4% 0.91 US$6,821
2025-04-14 2025-04-11 B Purchase

Chief Medical Officer

Executive Director
20,000 +1.9%
0.80
US$16,000
20,000 +1.9% 0.80 US$16,000
2025-04-10 2025-04-10 B Purchase

VP Controller and PAO

Officer
6,500 +106.6%
0.79
US$5,135
6,500 +106.6% 0.79 US$5,135
2025-04-10 2025-04-09 B Purchase

VP Controller and PAO

Officer
6,000 +6315.8%
0.80
US$4,800
6,000 +6315.8% 0.80 US$4,800
2025-04-10 2025-04-09 B Purchase

Chief Medical Officer

Executive Director
30,000 +2.9%
0.81
US$24,399
30,000 +2.9% 0.81 US$24,399
2025-04-10 2025-04-09 B Purchase

Chief Executive Officer

Executive Director
10,000 +3.3%
0.83
US$8,300
10,000 +3.3% 0.83 US$8,300
2025-04-10 2025-04-08 B Purchase

VP Controller and PAO

Officer
95 +inf%
0.80
US$76
95 +inf% 0.80 US$76
2025-04-09 2025-04-08 B Purchase Non-Executive Director
12,050 +35.8%
0.85
US$10,218
12,050 +35.8% 0.85 US$10,218
2025-04-09 2025-04-08 B Purchase

Chief Medical Officer

Executive Director
26,000 +2.5%
0.84
US$21,840
26,000 +2.5% 0.84 US$21,840
2025-04-08 2025-04-07 B Purchase

Chief Executive Officer

Executive Director
10,000 +3.4%
0.83
US$8,300
10,000 +3.4% 0.83 US$8,300
2024-01-30 2024-01-26 B Purchase

Chief Executive Officer

Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase Non-Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase Non-Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase

Chief Medical Officer

Executive Director
40,983
0.00
US$0
40,983 0.00 US$0
2024-01-30 2024-01-26 B Purchase Non-Executive Director
8,196
0.00
US$0
8,196 0.00 US$0
2023-10-04 2023-10-03 B Purchase

Chief Operating Officer

Officer
800 +266.7%
1.05
US$836
800 +266.7% 1.05 US$836
2023-10-04 2023-10-03 B Purchase

Chief Operating Officer

Officer
300 +inf%
1.05
US$315
300 +inf% 1.05 US$315
2022-06-09 2022-06-07 B Purchase

Chief Medical Officer

Executive Director Large shareholder
5,182 +400.2%
1.93
US$10,001
5,182 +400.2% 1.93 US$10,001
2022-05-23 2022-05-19 B Purchase

Chief Executive Officer

Executive Director
5,500 +2.2%
2.05
US$11,275
5,500 +2.2% 2.05 US$11,275